BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31605326)

  • 21. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma.
    Waterman TA; Hagen JA; Peters JH; DeMeester SR; Taylor CR; Demeester TR
    Ann Thorac Surg; 2004 Oct; 78(4):1161-9; discussion 1161-9. PubMed ID: 15464464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy comparison between two-field and three-field lymphadenectomy for thoracic esophageal squamous cell carcinoma].
    Lin D; Ye T; Ma L; Shao L; Song Z; Jiang S; Xiang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):990-994. PubMed ID: 27680065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
    Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
    Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the nodal status in the 7th edition of the UICC-TNM classification for esophageal squamous cell carcinoma: proposed modifications for improved survival stratification : impact of lymph node metastases on overall survival after esophagectomy.
    Yamasaki M; Miyata H; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
    Ann Surg Oncol; 2014 Sep; 21(9):2850-6. PubMed ID: 24728822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival in lymph node negative adenocarcinoma of the esophagus after R0 resection with and without neoadjuvant therapy: evidence for downstaging of N status.
    Leers JM; Ayazi S; Hagen JA; Terterov S; Klipfel N; Oezcelik A; Abate E; Lipham JC; DeMeester SR; Banki F; DeMeester TR
    J Am Coll Surg; 2009 Apr; 208(4):553-6. PubMed ID: 19476789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is there a role for radical esophagectomy.
    Lerut T; Coosemans W; De Leyn P; Decker G; Deneffe G; Van Raemdonck D
    Eur J Cardiothorac Surg; 1999 Sep; 16 Suppl 1():S44-7. PubMed ID: 10536946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extent of lymphadenectomy does not predict survival in patients treated with primary esophagectomy.
    Wong J; Weber J; Almhanna K; Hoffe S; Shridhar R; Karl R; Meredith KL
    J Gastrointest Surg; 2013 Sep; 17(9):1562-8; discussion 1569. PubMed ID: 23818125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction.
    Mine S; Watanabe M; Kumagai K; Okamura A; Yuda M; Hayami M; Yamashita K; Imamura Y; Ishizuka N
    Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30791046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Lymph Node Yield on Overall Survival in Patients Treated With Neoadjuvant Chemoradiotherapy Followed by Esophagectomy for Cancer: A Population-based Cohort Study in the Netherlands.
    Visser E; van Rossum PSN; Ruurda JP; van Hillegersberg R
    Ann Surg; 2017 Nov; 266(5):863-869. PubMed ID: 28742691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Value of Lymph Node Yield on Overall Survival in Esophageal Cancer Patients: A Systematic Review and Meta-analysis.
    Visser E; Markar SR; Ruurda JP; Hanna GB; van Hillegersberg R
    Ann Surg; 2019 Feb; 269(2):261-268. PubMed ID: 29794846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial.
    Omloo JM; Lagarde SM; Hulscher JB; Reitsma JB; Fockens P; van Dekken H; Ten Kate FJ; Obertop H; Tilanus HW; van Lanschot JJ
    Ann Surg; 2007 Dec; 246(6):992-1000; discussion 1000-1. PubMed ID: 18043101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylactic Cervical Lymph Node Dissection in Thoracoscopic Esophagectomy for Esophageal Cancer Increases Postoperative Complications and Does Not Improve Survival.
    Koterazawa Y; Oshikiri T; Takiguchi G; Hasegawa H; Yamamoto M; Kanaji S; Yamashita K; Matsuda T; Nakamura T; Fujino Y; Tominaga M; Suzuki S; Kakeji Y
    Ann Surg Oncol; 2019 Sep; 26(9):2899-2904. PubMed ID: 31187365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical management of esophageal sarcoma: a multicenter European experience.
    Mege D; Depypere L; Piessen G; Slaman AE; Wijnhoven BPL; Hölscher A; Nilsson M; van Berge Henegouwen MI; van Lanschot JJB; Schroeder W; Thomas PA; Nafteux P; D'Journo XB
    Dis Esophagus; 2018 Mar; 31(3):. PubMed ID: 29444281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Number of negative lymph nodes is associated with survival in thoracic esophageal squamous cell carcinoma patients undergoing three-field lymphadenectomy.
    Zhu Z; Chen H; Yu W; Fu X; Xiang J; Li H; Zhang Y; Sun M; Wei Q; Zhao W; Zhao K
    Ann Surg Oncol; 2014 Sep; 21(9):2857-63. PubMed ID: 24740827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transthoracic esophagectomy for adenocarcinoma of the oesophagus: standard versus extended two-field mediastinal lymphadenectomy?
    D'Journo XB; Doddoli C; Michelet P; Loundou A; Trousse D; Giudicelli R; Fuentes PA; Thomas PA
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):697-704. PubMed ID: 15784377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of increasing lymph node yield on staging, morbidity and survival after esophagectomy for esophageal adenocarcinoma.
    Henckens SPG; Hagens ERC; van Berge Henegouwen MI; Meijer SL; Eshuis WJ; Gisbertz SS
    Eur J Surg Oncol; 2023 Jan; 49(1):89-96. PubMed ID: 35933270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Worldwide Oesophageal Cancer Collaboration guidelines for lymphadenectomy predict survival following neoadjuvant therapy.
    Stiles BM; Nasar A; Mirza FA; Lee PC; Paul S; Port JL; Altorki NK
    Eur J Cardiothorac Surg; 2012 Oct; 42(4):659-64. PubMed ID: 22491667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors that influence early death due to cancer recurrence after extended radical esophagectomy with three-field lymph node dissection.
    Kosugi S; Kanda T; Yajima K; Ishikawa T; Hatakeyama K
    Ann Surg Oncol; 2011 Oct; 18(10):2961-7. PubMed ID: 21499809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term survival from adenocarcinoma of the esophagus after transthoracic and transhiatal esophagectomy.
    Ovrebo KK; Lie SA; Laerum OD; Svanes K; Viste A
    World J Surg Oncol; 2012 Jun; 10():130. PubMed ID: 22747995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.